CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The goal of this clinical research study is to learn if Niraparib can help to control metastatic pancreatic cancer. The safety of t...
Phase 2
Kansas City, Kansas, United States and 5 other locations
Pancreatic cancer is a deadly disease and will be the second leading cause of cancer related death behind lung cancer...
Phase 1, Phase 2
Kansas City, Kansas, United States
open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...
Phase 1, Phase 2
Kansas City, Kansas, United States and 15 other locations
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Kansas City, Kansas, United States and 108 other locations
Researchers want to discover if the new drug "TG01" will work with participants' bodies to help their immune system attack any cancer cells ...
Phase 2
Kansas City, Missouri, United States and 4 other locations
cancer, gastroesophageal junction cancer (GEJ cancer) or pancreatic cancer. GEJ is where the tube that ...
Phase 1
Westwood, Kansas, United States and 45 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.
Phase 3
Kansas City, Missouri, United States and 59 other locations
The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON...
Phase 1, Phase 2
Westwood, Kansas, United States and 31 other locations
and efficacy of 9-ING-41, a potent GSK-3β inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers...
Phase 2
Kansas City, Kansas, United States and 65 other locations
(PK) and pharmacodynamics of XL309 (previously ISM3091) administered alone or in combination with olaparib in participants with advanced solid tumors...
Phase 1
Kansas City, Missouri, United States and 15 other locations
Clinical trials
Research sites
Resources
Legal